Tirzepatide is a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://joycekwqb441216.alltdesign.com/tirzepatide-a-game-changer-for-type-2-diabetes-59285086